| Literature DB >> 35338171 |
Samantha K Millard1,2,3, Klara Bokelmann1, Rik Schalbroeck1, Nic J A van der Wee4, Nancy E E van Loey5,6, Antoinette I M van Laarhoven7,8,9.
Abstract
A large proportion of patients with burn injuries develop chronic itch, which impacts quality of life. The underlying pathophysiological mechanisms are poorly understood. This cross-sectional pilot study investigates whether altered cortical oscillatory processes are involved in chronic post-burn itch. Continuous electroencephalography (EEG) data were recorded during rest and stimulation of non-injured skin, inducing itch (histamine and electrical) and cold-pressor task pain for 15 adults with chronic post-burn itch and 15 matched healthy controls. Quantitative metrics comprised oscillatory power and peak frequencies in theta, alpha, and beta bands. No statistical differences between patients and healthy controls were found in oscillatory activity during rest or stimulation, with Bayesian analysis suggesting equivocal evidence. However, post-traumatic stress symptoms and duration of chronic itch may be associated with changes in oscillatory activity. A lack of differences in cortical oscillatory processing and itch levels at non-injured sites, suggests that itch symptoms have a localised character in this sample of patients with post-burn itch. For future studies, a biopsychological approach with integration of peripheral and central nervous system techniques, linear and non-linear EEG analysis, injured and non-injured stimulation sites, and incorporation of individual characteristics is recommended. Insight into pathophysiological mechanisms underlying chronic post-burn itch could improve diagnostics and treatments.Entities:
Mesh:
Year: 2022 PMID: 35338171 PMCID: PMC8956573 DOI: 10.1038/s41598-022-08742-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 2Topoplots visualising oscillatory power during resting state. (A) Topography of resting state theta (4–7.5 Hz) power (µV2) for patients with chronic post-burn itch and healthy controls. Averaged for healthy control participants during (A.a) eyes closed and (A.c) eyes open, and for chronic post-burn itch patients during (A.b) eyes closed and (A.d) eyes open. (B) Topography of resting state alpha (8–12.5 Hz) power (µV2) for patients with chronic post-burn itch and healthy controls. Averaged for healthy control participants during (B.a) eyes closed and (B.c) eyes open, and for chronic post-burn itch patients during (B.b) eyes closed and (B.d) eyes open. (C) Topography of resting state beta (13–30 Hz) power (µV2) for patients with chronic post-burn itch and healthy controls. Averaged for healthy control participants during (C.a) eyes closed and (C.c) eyes open, and for chronic post-burn itch patients during (C.b) eyes closed and (C.d) eyes open.
Comparison of global power and mean peak frequency outcomes between patients (n = 13) and healthy controls (HC; n = 14) during eyes closed (EC) and eyes open (EO) resting states.
| Frequency band | Mean (SD) patients | Mean (SD) HCs | Condition (EC/EO) | Group (patient/HC) | Condition * group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EC | EO | EC | EO | F (1,25) | ηG2 | BF10 | F (1,25) | ηG2 | BF10 | F (1,25) | ηG2 | BF10 | ||||
| Theta | .67 (.58) | .51 (.36) | .84 (.74) | .55 (.27) | 9.21 | .006** | .04 | 3.30 | .38 | .544 | .01 | .46 | .45 | .508 | < .01 | .41 |
| Alpha | 1.95 (2.31) | .73 (.93) | 1.81 (1.50) | .59 (.39) | 34.97 | < .001*** | .19 | 215.05 | .01 | .939 | < .01 | .38 | < .01 | .964 | < .01 | .36 |
| Beta | .20 (.17) | .18 (.14) | .20 (.12) | .18 (.11) | 1.98 | .172 | < .01 | .62 | < .01 | .949 | < .01 | .63 | .11 | .748 | < .01 | .39 |
| Theta | 5.67 (.35) | 5.50 (.31) | 5.79 (.56) | 5.56 (.42) | 24.51 | < .001*** | .06 | 506.02 | .21 | .651 | .01 | .55 | .21 | .652 | < .01 | .39 |
| Alpha | 10.04 (.57) | 10.01 (.32) | 9.81 (.56) | 9.96 (.52) | .96 | .338 | .01 | .41 | .45 | .509 | .01 | .52 | .73 | .402 | .01 | .47 |
| Beta | 17.19 (1.00) | 17.99 (.98) | 16.85 (.92) | 17.62 (1.22) | 17.13 | < .001*** | .14 | 101.59 | .91 | .350 | .03 | .50 | .03 | .876 | < .01 | .35 |
The displayed means are based on the untransformed variables. For theta and alpha power, the analysis of variance was conducted using square-root transformed variables. SD = standard deviation. η = generalised eta squared. BF10 = Bayes factor, evidence towards alternative hypothesis.
*p < .05; **p < .01; ***p < .001.
Figure 1Spectral analysis of resting state activity for patients with chronic post-burn itch (orange) and healthy controls (blue). Spectra of mean power of global resting state activity recorded from all electrodes in (a) healthy controls (HCs) with eyes closed, (b) patients with eyes closed, (c) HCs with eyes open, and (d) patients with eyes open. Individual lines represent individual participants for plots (a–d). (e) Plot of mean power spectra for HCs (blue) and patients (orange), with full lines representing eyes closed (EC) and dashed lines representing eyes open (EO) conditions. Frequency bands of interests are distinguished left to right as white (theta: 4–7.5 Hz), grey (alpha: 8–12.5 Hz), and white (13–30 Hz) panels. (f) Mean spectral energy ratio for theta:alpha. With eyes closed, there is less theta compared to alpha power, whereas with eyes open there is more theta compared to alpha power, for both patients (orange) and HCs (blue). The theta:alpha between the patients (EC: Mean (M) = .77, standard deviation (SD) = .45, n = 14; EO: M = 1.51, SD = .74, n = 13) and the HCs (EC: M = .95, SD = .72, n = 14; EO: M = 1.64, SD = .82, n = 14) was not statistically significant for EC (t(26) = .81, p = .428) or EO (t(25) = .41, p = .680).
Comparisons of global power outcomes (A) and mean peak frequency outcomes during histamine stimulation, (B) during electrical “must-scratch” threshold stimulation, and (C) during painful cold pressor task (CPT) stimulation between patients and healthy controls (HCs).
| t-test | |||||||
|---|---|---|---|---|---|---|---|
| Frequency band | Mean (SD) patients ( | Mean (SD) HCs ( | Mean difference (SE) | BF10 | |||
| Power | Theta | .49 (.23) | .55 (.24) | .06 (.10) | .63 | .534 | .45 |
| Alpha | .37 (.30) | .46 (.38) | .08 (.15) | .56 | .581 | .43 | |
| Beta | .19 (.14) | .19 (.13) | < .01 (.06) | .08 | .937 | .39 | |
| Mean peak | Theta | 5.42 (.20) | 5.53 (.36) | .11 (.13) | .87 | .396 | .51 |
| Alpha | 9.89 (.27) | 9.79 (.33) | −.09 (.13) | −.73 | .475 | .47 | |
| Beta | 18.28 (1.02) | 18.18 (1.04) | −.10 (.44) | −.23 | .822 | .39 | |
The displayed means are based on the untransformed variables. For the variables, in panel A, beta power, beta mean peak; in panel B, theta and beta power, and in panel C, all displayed frequency bands the t-tests were conducted using square-root transformed variables. SD = standard deviation. SE = standard error. df = degrees of freedom. BF10 = Bayes factor, evidence towards alternative hypothesis. IQR = inter-quartile range.
Spearman's correlation coefficient (r) between power and mean peak frequencies during rest, with eyes closed (EC) or eyes open (EO), and stimulation states in theta, alpha, and beta bands with patients’ duration of chronic itch experience.
| Theta | Alpha | Beta | ||||||
|---|---|---|---|---|---|---|---|---|
| Power | EC | 14 | −.76 | .002** | −.73 | .003** | −.77 | .001** |
| EO | 13 | −.67 | .013* | −.79 | .001** | −.69 | .010* | |
| Mean Peak | EC | 14 | −.63 | .016* | .21 | .469 | .13 | .658 |
| EO | 13 | −.81 | .001** | .22 | .481 | −.17 | .577 | |
| Power | 10 | −.46 | .185 | −.59 | .073 | −.69 | .028* | |
| Mean Peak | 10 | −.62 | .056 | .18 | .614 | .47 | .166 | |
| Power | 13 | −.45 | .127 | −.74 | .004** | −.74 | .004** | |
| Power | 11 | −.18 | .601 | −.57 | .070 | −.64 | .035* | |
*p < .05; **p < .01; ***p < .001.
Spearman's correlation coefficient (r) between power and mean peak frequencies during rest, with eyes closed (EC) or eyes open (EO), and stimulation states in theta, alpha, and beta frequency bands with patients’ score on the impact of event scale measuring post-traumatic stress symptoms.
| Theta | Alpha | Beta | ||||||
|---|---|---|---|---|---|---|---|---|
| Power | EC | 14 | −.24 | .411 | .08 | .793 | −.42 | .133 |
| EO | 13 | −.48 | .096 | −.07 | .830 | −.48 | .096 | |
| Mean Peak | EC | 14 | .20 | .486 | −.29 | .315 | −.13 | .061 |
| EO | 13 | −.15 | .627 | .23 | .457 | .66 | .844 | |
| Power | 10 | −.75 | .012* | −.71 | .021* | −.76 | .010* | |
| Mean Peak | 10 | −.45 | .197 | −.07 | .854 | .17 | .649 | |
| Power | 13 | −.50 | .085 | −.22 | .475 | −.27 | .372 | |
| Power | 11 | −.70 | .016* | −.68 | .022* | −.45 | .163 | |
*p < .05; **p < .01; ***p < .001.
Spearman's correlation coefficient (r) between power and mean peak frequencies during rest, with eyes closed (EC) or eyes open (EO), and stimulation states in theta, alpha, and beta frequency bands with patients’ total injured body surface area.
| Theta | Alpha | Beta | ||||||
|---|---|---|---|---|---|---|---|---|
| Power | EC | 14 | −.47 | .088 | −.28 | .335 | −.50 | .068 |
| EO | 13 | −.49 | .092 | −.28 | .360 | −.40 | .174 | |
| Mean Peak | EC | 14 | −.21 | .462 | .16 | .597 | −.11 | .707 |
| EO | 13 | −.19 | .526 | .18 | .550 | .08 | .808 | |
| Power | 10 | .60 | .070 | −.69 | .026* | −.74 | .014* | |
| Mean Peak | 10 | .45 | .194 | −.20 | .575 | .31 | .379 | |
| Power | 13 | −.51 | .076 | −.34 | .251 | −.42 | .156 | |
| Power | 11 | −.59 | .058 | −.50 | .121 | −.35 | .293 | |
*p < .05; **p < .01; ***p < .001.
Spearman's correlation coefficient (r) between (A) patients’ (B) healthy controls’ age and power and mean peak frequencies during rest, with eyes closed (EC) or eyes open (EO), and stimulation states in theta, alpha, and beta bands.
| Theta | Alpha | Beta | ||||||
|---|---|---|---|---|---|---|---|---|
| Power | EC | 14 | −.39 | .175 | −.15 | .615 | −.41 | .144 |
| EO | 13 | −.71 | .007** | −.41 | .168 | −.63 | .022* | |
| Mean Peak | EC | 14 | −.002 | .994 | −.49 | .078 | .61 | .021* |
| EO | 13 | −.14 | .655 | −.30 | .316 | .59 | .035* | |
| Power | 10 | −.87 | .001** | −.83 | .003** | −.62 | .054 | |
| Mean Peak | 10 | −.22 | .533 | −.47 | .174 | .76 | .011* | |
| Power | 13 | −.76 | .002** | −.63 | .021* | −.48 | .098 | |
| Power | 11 | −.88 | < .001*** | −.73 | .011* | −.53 | .096 | |
| Power | EC | 14 | −.14 | .637 | −.36 | .208 | −.23 | .436 |
| EO | 14 | −.05 | .876 | −.07 | .817 | .06 | .852 | |
| Mean Peak | EC | 14 | .04 | .887 | −.60 | .025* | .08 | .782 |
| EO | 14 | .04 | .887 | −.31 | .281 | −.07 | .805 | |
| Power | 10 | −.43 | .167 | −.31 | .331 | −.20 | .542 | |
| Mean Peak | 10 | .03 | .931 | −.41 | .183 | −.25 | .430 | |
| Power | 13 | −.29 | .334 | −.24 | .426 | −.13 | .681 | |
| Power | 12 | −.55 | .067 | −.23 | .471 | −.43 | .159 | |
*p < .05; **p < .01; ***p < .001.
Spearman's correlation coefficient (r) between power and mean peak frequencies during rest, with eyes closed (EC) or eyes open (EO), and stimulation states in theta, alpha, and beta frequency bands with baseline (A) pain ratings. (B) itch ratings in burn-injured patients. Individuals with pain unrelated to burns were excluded.
| Theta | Alpha | Beta | ||||||
|---|---|---|---|---|---|---|---|---|
| Power | EC | 12 | .27 | .396 | .08 | .817 | .14 | .667 |
| EO | 11 | −.16 | .640 | .12 | .716 | −.11 | .738 | |
| Mean Peak | EC | 12 | .36 | .256 | .22 | .490 | −.01 | .972 |
| EO | 11 | .39 | .239 | −.50 | .120 | .54 | .085 | |
| Power | 10 | −.44 | .203 | −.28 | .441 | < .01 | 1.00 | |
| Mean Peak | 10 | −.06 | .880 | −.08 | .821 | .55 | .099 | |
| Power | 12 | −.15 | .650 | .05 | .880 | .25 | .431 | |
| Power | 11 | −.43 | .188 | −.26 | .433 | .05 | .884 | |
| Power | EC | 14 | .20 | .493 | −.10 | .739 | .14 | .644 |
| EO | 13 | .08 | .793 | −.01 | .978 | .06 | .835 | |
| Mean Peak | EC | 14 | .11 | .711 | .31 | .286 | .10 | .734 |
| EO | 13 | .24 | .431 | −.41 | .165 | .46 | .115 | |
| Power | 10 | .25 | .490 | .34 | .335 | .30 | .404 | |
| Mean Peak | 10 | −.30 | .394 | .63 | .053 | −.16 | .669 | |
| Power | 13 | .32 | .290 | .48 | .095 | .32 | .286 | |
| Power | 11 | .23 | .503 | .38 | .244 | .23 | .503 | |